Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1)

We report a case of ceftriaxone-induced immune hemolytic anemia in a 10-year-old with chronic active Epstein–Barr virus disease and hemophagocytic lymphohistiocytosis. After chemotherapy, she became febrile and received ceftriaxone. She rapidly developed respiratory failure and anemia. Her direct an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunnion, Kenji M., Feagin, Lisa M., Chicella, Michael F., Kaszowski, Cortney L., Hair, Pamela S., Price, Jessica, Owen, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374879/
https://www.ncbi.nlm.nih.gov/pubmed/30838143
http://dx.doi.org/10.1155/2019/4105653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374879/
https://www.ncbi.nlm.nih.gov/pubmed/30838143
http://dx.doi.org/10.1155/2019/4105653

Ejemplares similares